Zhipeng Zou
- Molecular Biology top 10%
- Cancer Research top 10%
- Oncology
- Immunology
- Physiology
- Topics
- PI3K/AKT/mTOR signaling in cancer (8 papers)Ubiquitin and proteasome pathways (4 papers)Bone Metabolism and Diseases (4 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryNature Communications
- Partner nations
- ChinaUnited StatesAustria
In The Last Decade
Zhipeng Zou
45 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 115
- Molecular Biology 802
- Cancer Research 221
- Oncology 171
- Immunology 136
- Physiology 110
Countries citing papers authored by Zhipeng Zou
This map shows the geographic impact of Zhipeng Zou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhipeng Zou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhipeng Zou more than expected).
Fields of papers citing papers by Zhipeng Zou
This network shows the impact of papers produced by Zhipeng Zou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhipeng Zou. The network helps show where Zhipeng Zou may publish in the future.
Co-authorship network of co-authors of Zhipeng Zou
This figure shows the co-authorship network connecting the top 25 collaborators of Zhipeng Zou. A scholar is included among the top collaborators of Zhipeng Zou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhipeng Zou. Zhipeng Zou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 11 | |
| 5 | 4 | |
| 6 | 26 | |
| 7 | 23 | |
| 8 | 33 | |
| 9 | 26 | |
| 10 | 6 | |
| 11 | 87 | |
| 12 | 10 | |
| 13 | 26 | |
| 14 | 12 | |
| 15 | 44 | |
| 16 | 22 | |
| 17 | 41 | |
| 18 | 2 | |
| 19 | 8 | |
| 20 | 50 |
About Zhipeng Zou
Zhipeng Zou is a scholar working on Aging, Molecular Biology and Cancer Research, having authored 48 papers that have together received 1.3k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (8 papers), Ubiquitin and proteasome pathways (4 papers) and Bone Metabolism and Diseases (4 papers). The work is most often cited by research in Cancer Research (221 citations), Orthopedics and Sports Medicine (102 citations) and Molecular Biology (802 citations). Zhipeng Zou has collaborated with scholars based in China, United States and Austria. Frequent co-authors include Xiaochun Bai, Anling Liu, Shen-qiu Luo, Xiumei Li, Zhongming Zhang, Weisen Zeng, Di Lü, Qiancheng Song, Yu Jiang and Zhigao Wang. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.